Nucleic Acid-Conjugated Polymeric Nanoparticles for Gene Therapy
Exclusively Licensed
Invention type: Technology
/
Case number: #23628JQ
A nanoparticle composition including: a first polymer conjugated to a drug by a linker to form a first polymer compound, the first polymer compound having a net negative charge; and a second polymer conjugated to at least one positively charged group to form a second polymer compound, the second polymer compound having a net positive charge, and the first polymer compound and the second polymer compound interacting electrostatically to form a nanoparticle.
Researchers
Natalie Artzi
/
Alexander M Cryer
/
Pere Dosta Pons
Departments: Institute for Medical Engineering and Science
Technology Areas: Chemicals & Materials: Catalysis & Synthesis, Nanotechnology & Nanomaterials, Polymers / Drug Delivery: Microparticles & Nanoparticles / Therapeutics: Nucleic Acids
Impact Areas: Healthy Living
-
nucleic acid-conjugated polymeric nanoparticles and methods of use
European Patent Convention | Published application -
nucleic acid-conjugated polymeric nanoparticles and methods of use
United States of America | Published application
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.